Margaret Kyle

2.3k total citations
41 papers, 999 citations indexed

About

Margaret Kyle is a scholar working on Economics and Econometrics, Management of Technology and Innovation and Strategy and Management. According to data from OpenAlex, Margaret Kyle has authored 41 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Economics and Econometrics, 17 papers in Management of Technology and Innovation and 7 papers in Strategy and Management. Recurrent topics in Margaret Kyle's work include Pharmaceutical Economics and Policy (20 papers), Intellectual Property and Patents (17 papers) and Innovation Policy and R&D (11 papers). Margaret Kyle is often cited by papers focused on Pharmaceutical Economics and Policy (20 papers), Intellectual Property and Patents (17 papers) and Innovation Policy and R&D (11 papers). Margaret Kyle collaborates with scholars based in United States, France and United Kingdom. Margaret Kyle's co-authors include Anita M. McGahan, Henry G. Grabowski, Ernst R. Berndt, John M. de Figueiredo, Davina C. Ling, David B. Ridley, Mercedes Delgado, Heidi Williams, Emeric Henry and Dave Donaldson and has published in prestigious journals such as American Economic Review, Strategic Management Journal and The Quarterly Journal of Economics.

In The Last Decade

Margaret Kyle

39 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret Kyle United States 16 792 348 156 148 66 41 999
Kurt Richard Brekke Norway 21 1.2k 1.6× 84 0.2× 166 1.1× 140 0.9× 22 0.3× 76 1.5k
Sara Fisher Ellison United States 14 559 0.7× 58 0.2× 212 1.4× 83 0.6× 19 0.3× 26 915
Joseph H. Golec United States 19 849 1.1× 51 0.1× 159 1.0× 41 0.3× 43 0.7× 76 1.5k
Danielle Li United States 12 338 0.4× 108 0.3× 64 0.4× 18 0.1× 103 1.6× 24 734
W. Duncan Reekie South Africa 14 284 0.4× 46 0.1× 100 0.6× 48 0.3× 15 0.2× 55 500
Clark Nardinelli United States 16 659 0.8× 43 0.1× 28 0.2× 47 0.3× 42 0.6× 37 1.0k
Lía Hasenclever Brazil 10 153 0.2× 82 0.2× 198 1.3× 12 0.1× 55 0.8× 76 487
Amy Kapczynski United States 15 256 0.3× 188 0.5× 68 0.4× 36 0.2× 97 1.5× 47 611
Michael A. Santoro United States 15 172 0.2× 24 0.1× 183 1.2× 41 0.3× 39 0.6× 32 647
Gary M. Fournier United States 14 337 0.4× 29 0.1× 68 0.4× 17 0.1× 7 0.1× 32 585

Countries citing papers authored by Margaret Kyle

Since Specialization
Citations

This map shows the geographic impact of Margaret Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Kyle more than expected).

Fields of papers citing papers by Margaret Kyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Kyle. The network helps show where Margaret Kyle may publish in the future.

Co-authorship network of co-authors of Margaret Kyle

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Kyle. A scholar is included among the top collaborators of Margaret Kyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Kyle. Margaret Kyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kyle, Margaret & Anne Perrot. (2020). Pharmaceutical innovation: How can France catch up?. 1–12. 1 indexed citations
2.
Kyle, Margaret. (2016). Experts and Financial Ties: Evidence from FDA Advisory Committees. 1 indexed citations
3.
Costinot, Arnaud, Dave Donaldson, Margaret Kyle, & Heidi Williams. (2016). The More We Die, The More We Sell? A Simple Test of the Home-Market Effect. HAL (Le Centre pour la Communication Scientifique Directe). 40 indexed citations
4.
Henry, Emeric, et al.. (2015). Competition and the Efficiency of Markets for Technology. Management Science. 62(4). 1000–1019. 29 indexed citations
5.
Delgado, Mercedes, Margaret Kyle, & Anita M. McGahan. (2013). Intellectual Property Protection and the Geography of Trade. Journal of Industrial Economics. 61(3). 733–762. 63 indexed citations
6.
Kyle, Margaret & Anita M. McGahan. (2012). Pharmaceutical Investments Before and After TRIPS. Toulouse Capitole Publications (University Toulouse 1 Capitole). 1 indexed citations
7.
Bärnighausen, Till, Margaret Kyle, Joshua A. Salomon, & Brenda Waning. (2011). Assessing the population health impact of market interventions to improve access to antiretroviral treatment. Health Policy and Planning. 27(6). 467–476. 4 indexed citations
8.
Grabowski, Henry G., Margaret Kyle, Richard Mortimer, Genia Long, & Noam Y. Kirson. (2011). Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act. Health Affairs. 30(11). 2157–2166. 25 indexed citations
10.
Kyle, Margaret, et al.. (2008). Does Reimportation Reduce Price Differences for Prescription Drugs? Lessons from the European Union. Health Services Research. 43(4). 1308–1324. 21 indexed citations
11.
Kyle, Margaret. (2007). Strategic Responses to Parallel Trade. The B E Journal of Economic Analysis & Policy. 11(2). 2 indexed citations
12.
Kyle, Margaret & David B. Ridley. (2007). Would Greater Transparency And Uniformity Of Health Care Prices Benefit Poor Patients?. Health Affairs. 26(5). 1384–1391. 42 indexed citations
13.
Grabowski, Henry G. & Margaret Kyle. (2007). Generic competition and market exclusivity periods in pharmaceuticals. Managerial and Decision Economics. 28(4-5). 491–502. 108 indexed citations
14.
Furman, Jeffrey L., Margaret Kyle, Iain Cockburn, & Rebecca Henderson. (2006). Knowledge Spillovers, Geographic Location, and the Productivity of Pharmaceutical Research. 4 indexed citations
15.
Figueiredo, John M. de & Margaret Kyle. (2006). Surviving the gales of creative destruction: the determinants of product turnover. Strategic Management Journal. 27(3). 241–264. 56 indexed citations
16.
Kyle, Margaret. (2006). The role of firm characteristics in pharmaceutical product launches. The RAND Journal of Economics. 37(3). 602–618. 65 indexed citations
17.
Furman, Jeffrey L., Margaret Kyle, Iain Cockburn, & Rebecca Henderson. (2005). Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research. Annals of Economics and Statistics. 165–188. 14 indexed citations
18.
Figueiredo, John M. de & Margaret Kyle. (2005). Surviving the Gales of Creative Destruction: The Determinants of Product Turnover. SSRN Electronic Journal. 4 indexed citations
19.
Kyle, Margaret. (2004). Does locale affect R&D productivity? the case of pharmaceuticals. FRB SF weekly letter. 2 indexed citations
20.
Berndt, Ernst R., Margaret Kyle, & Davina C. Ling. (2003). The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches. NBER Chapters. 229–274. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026